GlaxoSmithKline (GSK), a UK-listed drugs company, has set aside £50m ($78m) to launch a corporate venturing fund for the country’s early-stage healthcare companies and spin-outs from universities. The UK Venture Capital Fund will be part of GSK’s existing corporate venturing unit, SR One, and is similar in scope to semiconductor company Intel’s launch of regional funds and leadership of the $3.5bn Intel Invest in America Alliance. Founded in 1985, SR One has invested more than $600m in biotech companies and 70% of its current portfolio are US-based. The fund is being launched at the same time as GSK plans to build a drugs factory in the UK after a cut in the intellectual property (IP) tax rate to 10% from 28% for assets held through a so-called patent box. Deborah Harland, partner at SR One, said: "This week’s release was the first time the fund has been announced. It is subject to successful implementation of the patent box, the mechanism for which is now the subject of consultation and so more specific details will be communicated in due course." Andrew Witty, chief executive of GSK (pictured), said: "The successful introduction of the patent box will enable us to increase investment in communities where we have existing facilities by scaling up current manufacturing and building a significant new plant. "With a more IP-friendly environment, we also plan to launch a new UK venture capital fund and invest in new technologies such as green chemistry. In total, these new investments in the UK would be worth more than £500m."
Sectors
- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- Deal Data
- Video
- Subscribe
- Newsletters
- Community & Events
GSK sets aside £50m for UK deals
Dec 2, 2010 • James Mawson
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.Featured Content
FUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.